Brightlands Venture Partners Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
9
- Investments
-
66
- Portfolio
-
32
- Exits
-
20
Brightlands Venture Partners General Information
Description
Founded in 2014, Brightlands Venture Partners is a venture capital firm based in Geleen, Netherlands. The firm seeks to invest in the manufacturing, healthcare and nanotechnology sectors.
Contact Information
Investor Status
Actively Seeking New Investments
Trade Association
Dutch Venture Capital Association (NVP)
Primary Investor Type
Venture Capital
Primary Office
- Urmonderbaan 22
- 6167 RD Geleen
- Netherlands
Brightlands Venture Partners Investments (66)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Circularise | 17-Nov-2022 | Later Stage VC | 0000 | Business/Productivity Software | Generating Revenue | 0000 00000000 00.0 |
| 00000000000 | 20-Oct-2022 | 00000 00000 | 00000 | Business/Productivity Software | Generating Revenue | |
| 0+00 | 01-Sep-2022 | 00000 00000 | 00.000 | Cultivation | Generating Revenue | |
| 00000000 | 01-Aug-2022 | 00000 00000 | 00.00 | Surgical Devices | Clinical Trials - General | 000000 00000000000 00.0 |
| 0000 0000000 | 18-Jan-2022 | 00000 00000 | 00.000 | Therapeutic Devices | Product In Beta Test | 000 00000000 00.0 |
| 00000000 | 13-Jan-2022 | 00000 00000 | 00.000 | Environmental Services (B2B) | Generating Revenue | 000 00 0000 |
| 0000000 | 13-Dec-2021 | 00000 00000 | 00.000 | Information Services (B2C) | Generating Revenue | 000 00 0000 |
| 0000000000 | 17-Nov-2021 | 00000 00000 | 000.00 | Biotechnology | Clinical Trials - Phase 2 | 000000 00000000000 00.0 |
| Vertoro | 14-Oct-2021 | Early Stage VC | 00.000 | Energy Production | Generating Revenue | 000000 000000 00.0 |
| Qorium | 19-Jul-2021 | Later Stage VC | 000 | Synthetic Textiles | Generating Revenue | 0000 00000000 00.0 |
Brightlands Venture Partners Exits (20)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| BioActor | 22-Dec-2022 | Buyout/LBO | |
| 000000000000 | 01-Oct-2021 | 000000000 00000000 | |
| 00000000000 | 01-Apr-2020 | 000 00 00000000 | |
| 0000000000 | 26-Sep-2019 | 000000000000000000 | |
| 000000000 00000000 | 03-Jun-2019 | 00000 0000000000 | |
| 0000000 | 01-Jan-2019 | 000000000 00000000 | |
| 0000000 | 01-Jan-2019 | 000 00 00000000 | |
| 0000000 | 01-Jan-2019 | 000 00 00000000 | |
| ACS Biomarker | 01-Sep-2018 | Out of Business | |
| FABPulous | 01-Sep-2018 | Out of Business |
Brightlands Venture Partners Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Brightlands Venture Partners Team (15)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Casper Bruens | Founder & Managing Partner | 0 | 0 | 0 | Geleen, Netherlands |
| Kim de Boer | Partner | 0 | 0 | Geleen, Netherlands | |
| Marcel Lubben Ph.D | Partner | 0 | 0 | 0 | Geleen, Netherlands |
| Mary McCarthy Ph.D | Partner | 0 | 0 | Geleen, Netherlands | |
| Emma Palmen | Investment Analyst | Geleen, Netherlands |
Brightlands Venture Partners Co-Investors (39)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Limburg Business Development Fund | 7 | 0 | 0 |
|
|
| Limburg Development and Investment Company | 0 | 0 |
|
|
|
| Future Food Fund | 0 | 0 |
|
|
|
| Netherlands Enterprise Agency | 0 | 0 |
|
|
|
| ReumaNederland | 0 | 0 |
|
|